These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23439021)
1. Myocardial viability: whom, what, why, which, and how? Mc Ardle BA; Beanlands RS Can J Cardiol; 2013 Mar; 29(3):399-402. PubMed ID: 23439021 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging. Katikireddy CK; Mann N; Brown D; Van Tosh A; Stergiopoulos K Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):55-73. PubMed ID: 22149526 [TBL] [Abstract][Full Text] [Related]
3. Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction. Tajouri TH; Chareonthaitawee P Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):55-63. PubMed ID: 20014935 [TBL] [Abstract][Full Text] [Related]
4. Viability by MRI or PET would not have changed the results of the STICH trial. Asrani NS; Chareonthaitawee P; Pellikka PA Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378 [TBL] [Abstract][Full Text] [Related]
5. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit. Mielniczuk LM; Beanlands RS Circ Cardiovasc Imaging; 2012 Mar; 5(2):262-70; discussion 270. PubMed ID: 22438424 [No Abstract] [Full Text] [Related]
6. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Dowsley T; Al-Mallah M; Ananthasubramaniam K; Dwivedi G; McArdle B; Chow BJ Can J Cardiol; 2013 Mar; 29(3):285-96. PubMed ID: 23357601 [TBL] [Abstract][Full Text] [Related]
7. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414 [TBL] [Abstract][Full Text] [Related]
8. The assessment of ischaemic burden: thoughts on definition and quantification. Nagel E; Shaw LJ Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):610-1. PubMed ID: 24618661 [No Abstract] [Full Text] [Related]
10. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET. Demirkol MO Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637 [TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587 [TBL] [Abstract][Full Text] [Related]
12. Revascularization in severe left ventricular dysfunction: the role of viability testing. Chareonthaitawee P; Gersh BJ; Araoz PA; Gibbons RJ J Am Coll Cardiol; 2005 Aug; 46(4):567-74. PubMed ID: 16098417 [TBL] [Abstract][Full Text] [Related]
13. Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches. Weissman G; Asch FM J Cardiovasc Transl Res; 2009 Mar; 2(1):24-9. PubMed ID: 20559966 [TBL] [Abstract][Full Text] [Related]
14. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R; Trials; 2013 Jul; 14():218. PubMed ID: 23866673 [TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial viability by nuclear imaging techniques. Bax JJ; Poldermans D; Elhendy A; Boersma E; van der Wall EE Curr Cardiol Rep; 2005 Mar; 7(2):124-9. PubMed ID: 15717959 [TBL] [Abstract][Full Text] [Related]
17. Letter from the editors: positron emission tomography radiopharmaceuticals-current status. Freeman LM; Blaufox MD Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558 [No Abstract] [Full Text] [Related]
18. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function. Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903 [TBL] [Abstract][Full Text] [Related]
19. Assessment of myocardial viability in chronic ischemic heart disease: current status. Rizzello V; Poldermans D; Bax JJ Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138 [TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial viability: review of the clinical significance. Ramos M; DePasquale E; Coplan NL Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]